Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma

Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma

Purpose: The purpose of this study was to evaluate a cost-effectiveness analysis of hepatic arterial infusion chemotherapy with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX-HAIC) as the first-line treatment for patients with large unresectable hepatocellular carcinoma (HCC) compared...

Full description

Bibliographic Details
Main Authors: Haixia Zhang, Xiaohui Zeng, Ye Peng, Chongqing Tan, Xiaomin Wan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
FOLFOX-HAIC
TACE
cost-effectiveness
hepatocellular carcinoma
Markov model
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.849189/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.849189/full

Similar Items